Status:
COMPLETED
RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Rheumatology Research Foundation
Conditions:
Scleroderma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The researchers seek to understand if the Resilience-based, Energy Management to Enhance Wellbeing and Fatigue (RENEW) program helps with scleroderma symptom management and disease burden. The researc...
Eligibility Criteria
Inclusion
- Have a diagnosis of Systemic Sclerosis (SSc), any subtype
- Report a mean score of at least 4 on the Fatigue Severity Scale; potential mean range 1-9
- Have access to a computer and an internet connection
- Are able to speak and read English.
Exclusion
- Currently undergoing structured rehabilitation or psychological treatment.
- Other issues that preclude meaningful participation in study procedures (e.g. concurrent or complex medical issues, inability to access RENEW intervention, etc.)
Key Trial Info
Start Date :
August 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 29 2023
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT04908943
Start Date
August 28 2021
End Date
May 29 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109